SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : A list of Under Valued Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (20)12/29/1998 3:21:00 AM
From: Stephen D. Wilson  Read Replies (3) | Respond to of 30
 
I think it would be beneficial to all of the readers of this board to have an expectation that if you post you will give some background info along with the stock and not just stick a bunch of symbols up there.

I would also like to see one stock per post.
Thanks

Steve



To: Walter Morton who wrote (20)12/31/1998 7:42:00 PM
From: Walter Morton  Respond to of 30
 
CIST is a small company with $5.3 million in cash and another $3 million coming in from the IMNX $25 million out of court settlement.
The cash + no debt is reason enough for another company to want to buy CIST, but CIST has enough cash to buy a company with 20 times more sales. Also CIST has a $33 million agreement with the largest vaccine manufacture in the world and is receiving payments from them for research.

Here is the latest news:
cistronbio.com



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News